Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about DNA REPAIR: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
DNA REPAIR is a concept in neurodegeneration research. Key relationships include: co discussed, contributes to, inhibits. Associated with HUNTINGTON, TUMOR. Connected to 13 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | DNA REPAIR |
| Key Genes/Proteins | ABCB1, ALOX12, ALOX5, BRCA1, CD38, CGAS |
| Related Diseases | BREAST CANCER, CANCER, COLORECTAL CANCER |
graph TD
DNA_REPAIR["DNA REPAIR"]
APE2["APE2"] -->|"participates in"| DNA_REPAIR
CGAS["CGAS"] -->|"regulates"| DNA_REPAIR
cGAS["cGAS"] -->|"regulates"| DNA_REPAIR
IRF3["IRF3"] -->|"activates"| DNA_REPAIR
MAX["MAX"] -->|"activates"| DNA_REPAIR
PARP1["PARP1"] -->|"activates"| DNA_REPAIR
STING["STING"] -->|"activates"| DNA_REPAIR
CLOCK["CLOCK"] -->|"regulates"| DNA_REPAIR
P53["P53"] -->|"inhibits"| DNA_REPAIR| Target | Relation | Type | Str |
|---|---|---|---|
| Radiotherapy Resistance | contributes_to | phenotype | 0.90 |
| Frontotemporal Dementia | associated_with | disease | 0.85 |
| Neuronal Functions | protects_against | phenotype | 0.85 |
| Chromatin Organization | modulates | mechanism | 0.80 |
| DNA DAMAGE | associated_with | concept | 0.50 |
| Proteins | interacts_with | protein | 0.50 |
| HUNTINGTON'S | associated_with | concept | 0.50 |
| T Cell | therapeutic_target | cell_type | 0.50 |
| Neuron | activates | cell_type | 0.50 |
| Neuron | contributes_to | cell_type | 0.50 |
| T Cell | associated_with | cell_type | 0.50 |
| HOMOLOGOUS RECOMBINATION | activates | concept | 0.50 |
| CELL DEATH | inhibits | concept | 0.50 |
| Ovarian Cancer | inhibits | disease | 0.50 |
| Epithelial | activates | cell_type | 0.50 |
| BREAST CANCER | regulates | disease | 0.50 |
| Reactive Oxygen Species | regulates | process | 0.50 |
| GENETIC MODIFIERS | interacts_with | concept | 0.50 |
| PI3K/AKT/mTOR | associated_with | pathway | 0.50 |
| BREAST CANCER | associated_with | disease | 0.50 |
| T Cell | expressed_in | cell_type | 0.50 |
| Microglia | associated_with | cell_type | 0.50 |
| Neuron | causes | cell_type | 0.50 |
| Macrophage | causes | cell_type | 0.50 |
| Macrophage | activates | cell_type | 0.50 |
| T Cell | activates | cell_type | 0.50 |
| Proteins | associated_with | protein | 0.50 |
| SRPK1 | interacts_with | concept | 0.50 |
| Neuron | therapeutic_target | cell_type | 0.50 |
| Macrophage | biomarker_for | cell_type | 0.50 |
| HUNTINGTON'S DISEASE | co_discussed | disease | 0.40 |
| HUNTINGTON | co_discussed | disease | 0.40 |
| MICRORNA REGULATION | regulates | process | 0.35 |
| NEURON | associated_with | cell_type | 0.35 |
| NEURON | regulates | cell_type | 0.35 |
| PARP1 | associated_with | gene | 0.35 |
| KEAP1 | activates | gene | 0.35 |
| NRF2 | activates | gene | 0.35 |
| NEURON | activates | cell_type | 0.35 |
| HUNTINGTON | therapeutic_target | disease | 0.35 |
| HUNTINGTON | interacts_with | disease | 0.35 |
| TP53 | inhibits | gene | 0.30 |
| PARP1 | regulates | gene | 0.30 |
| Source | Relation | Type | Str |
|---|---|---|---|
| P53 | inhibits | gene | 1.00 |
| Als | regulates | disease | 1.00 |
| Cancer | regulates | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| Cancer | inhibits | disease | 1.00 |
| APOPTOSIS | regulates | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| CANCER | inhibits | gene | 1.00 |
| DNA | inhibits | gene | 1.00 |
| DNA | activates | gene | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| CANCER | regulates | gene | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| DNA | associated_with | gene | 1.00 |
| Senescence | regulates | disease | 1.00 |
| DNA | regulates | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| AUTOPHAGY | regulates | gene | 1.00 |
| P53 | regulates | gene | 1.00 |
| Als | activates | disease | 1.00 |
| APOPTOSIS | inhibits | gene | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| Cancer | associated_with | disease | 0.95 |
| CGAS | inhibits | protein | 0.95 |
| Tumor | inhibits | disease | 0.95 |
| Circadian Clock | modulates | pathway | 0.95 |
| NUCLEAR CGAS | associated_with | protein | 0.95 |
| Circadian Clock | modulates | process | 0.95 |
| miR-139-5p | regulates | biomarker | 0.95 |
| Nad | involved_in | compound | 0.95 |
| STAT6 | promotes | protein | 0.92 |
| P53 | inhibits | gene | 0.90 |
| TP53 | regulates | gene | 0.90 |
| P53 | regulates | gene | 0.90 |
| PARP | involved_in | protein | 0.90 |
| miR-139-5p | inhibits | biomarker | 0.90 |
| CGAS | suppresses | protein | 0.90 |
| PCNA | participates_in | protein | 0.90 |
| PARP1 | mediates | gene | 0.90 |
| APE2 | participates_in | gene | 0.90 |
| DNA | therapeutic_target | gene | 0.90 |
| Tumor | therapeutic_target | disease | 0.90 |
| Tumor | associated_with | disease | 0.90 |
| OXIDATIVE STRESS | activates | gene | 0.90 |
| GENES | therapeutic_target | gene | 0.90 |
| DNA | causes | gene | 0.90 |
| PSME2 | associated_with | gene | 0.85 |
| Als | associated_with | disease | 0.85 |
| CLOCK | modulates | entity | 0.85 |
| PARP1 | involved_in | entity | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Oligodendrocyte DNA Repair Enhancement Therapy | 0.665 | neurodegeneration | Cell type vulnerability in Alzheimer's D |
| Oligodendrocyte DNA Repair Enhancement | 0.550 | neurodegeneration | Cell type vulnerability in Alzheimers Di |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Overexpression of the ERG oncogene in prostate cancer identifies candidates for [PMID:41632544] | Köcher S, Elsesy ME, Moustafa A, Mohamma | J Clin Invest | 2026 | 0 |
| Genetic variations in base excision repair genes and the risk of developing hepa [PMID:41844453] | Shao B, Yin H, Zhang S, He S, Lu H et al | Cancer Genet | 2026 | 0 |
| Parkinson's disease linked LRRK2 G2019S drives oxidative nuclear DNA damage and [PMID:41889852] | Liu J, Gonzalez-Hunt CP, Richbourg T, Ba | bioRxiv : the preprint server | 2026 | 0 |
| PARG inhibition sequesters nuclear PAR-binding proteins, including XRCC1 and its [PMID:41890038] | Dumoulin I, Lee BJ, Zhang C, Lin X, Wang | bioRxiv | 2026 | 0 |
| Function of HIF-1α in Regulation of Antioxidative Stress of Tribolium castaneum [PMID:41899005] | Wan Z, Li X, Wang Y, Miao S, Chen Z et a | Insects | 2026 | 0 |
| Versatile and sensitive detection of mono- and poly(ADP-ribosyl)ation reveals XR [PMID:41922367] | Dauben H, Mihaljević M, Kolvenbach A, Pa | Nat Commun | 2026 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning DNA REPAIR in their description or question text
No additional research found